<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">HJFNS</journal-id><journal-title-group><journal-title>Hans Journal of Food and Nutrition Science</journal-title></journal-title-group><issn pub-type="epub">2166-613X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/HJFNS.2021.103021</article-id><article-id pub-id-type="publisher-id">HJFNS-43603</article-id><article-categories><subj-group subj-group-type="heading"><subject>HJFNS20210300000_75757946.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  双酚A的生理毒代动力学(PBTK)模型构建研究
   Construction of the Physiological Toxicokinetic Model of Bisphenol A
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>益宁</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>胡</surname><given-names>曼</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>周</surname><given-names>颖</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>复旦大学公共卫生学院，上海</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>06</month><year>2021</year></pub-date><volume>10</volume><issue>03</issue><fpage>175</fpage><lpage>189</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   双酚A (BPA)作为一种高产量的化学品，用于许多消费产品，如聚碳酸酯塑料、环氧树脂和热敏纸等。由于BPA的普遍存在性，与BPA接触相关的潜在影响，以及人类血清中异常高的BPA水平，一直是围绕BPA安全性争论的焦点，更好地解决这些争议的一个重要因素是描述BPA在人体中的药代动力学行为的基础过程。基于生理的药代动力学(PBPK)模型，将生理和生化信息整合到一个机制框架中，已广泛用于人类健康风险评估，定量描述化学物质及其代谢产物在人体中的药代动力学。本研究旨在既往研究基础上结合最新的毒理学研究结果，对模型结构进行了优化，主要体现在：a) 补充小肠的动脉血供、实现小肠的血液循环；b) 补充肾脏隔室；c) 去除肠肝循环过程。以产生毒性效应的非结合型BPA为指标，结果显示：优化后模型能更好地模拟人体膳食摄入BPA后血浆中非结合型BPA的浓度变化趋势。模型预测结果与实测值相近，优于既往研究结果，拟合效果良好。通过更新模型结构、优化模型参数和评价模型预测能力与可靠性等，拟建立一个汉族成年人(&gt;18岁)经口摄入BPA的PBTK模型，实现膳食摄入场景下定量预测血液中BPA主要存在形式(未结合态BPA、BPAG和BPAS)的浓度–
   时间曲线，以及尿液中总BPA的浓度
   –时间曲线。该模型可为BPA暴露的健康风险评估提供技术支撑。 As a high yield chemical, bisphenol A (BPA) is used in many consumer products, such as polycarbonate plastics, epoxy resins, and thermal paper. Due to the prevalence of BPA, the potential effects associated with BPA exposure, and the abnormally high levels of BPA in human serum, have been the focus of debate surrounding the safety of BPA. An important factor in better resolving these controversies is to describe the underlying processes of the pharmacokinetic behavior of BPA in humans physiology-based pharmacokinetics (PBPK) models, which integrate physiological and biochemical information into a mechanistic framework, have been widely used in human health risk assessment to quantitatively describe the pharmacokinetics of chemicals and their metabolites in the human body. Based on previous studies and combined with the latest results of toxicological studies, this study optimized the structure of the model, which was mainly reflected in the following aspects: a) replenish the arterial blood supply of small intestine to achieve blood circulation of small intestine; b) supplement of renal compartment; c) the removal of enterohepatic circulation was based on unbound BPA, which had toxic effects, and the results showed that the optimized model could better simulate the trend of plasma unbound BPA concentration after dietary BPA intake. The predicted results of the model are close to the measured values, which is better than the previous research results. The fitting effect is good By updating the model structure, optimizing the model parameters and evaluating the prediction ability and reliability of the model, a Han adult (&gt;18 years old) to quantitatively predict the time-concentration curves of the major forms of BPA (unbound BPA, BPAG and BPAS) in blood and total BPA in urine under dietary intake scenarios. This model can provide technical support for health risk assessment of BPA exposure. 
  
 
</p></abstract><kwd-group><kwd>双酚A，生理毒代动力学模型，健康风险评估，人群,  Bisphenol A</kwd><kwd> Physiologically Based Toxi-cokinetics</kwd><kwd> PBTK</kwd><kwd> Health Risk Assessment</kwd><kwd> Human</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>双酚A (BPA)作为一种高产量的化学品，用于许多消费产品，如聚碳酸酯塑料、环氧树脂和热敏纸等。由于BPA的普遍存在性，与BPA接触相关的潜在影响，以及人类血清中异常高的BPA水平，一直是围绕BPA安全性争论的焦点，更好地解决这些争议的一个重要因素是描述BPA在人体中的药代动力学行为的基础过程。基于生理的药代动力学(PBPK)模型，将生理和生化信息整合到一个机制框架中，已广泛用于人类健康风险评估，定量描述化学物质及其代谢产物在人体中的药代动力学。本研究旨在既往研究基础上结合最新的毒理学研究结果，对模型结构进行了优化，主要体现在：a) 补充小肠的动脉血供、实现小肠的血液循环；b) 补充肾脏隔室；c) 去除肠肝循环过程。以产生毒性效应的非结合型BPA为指标，结果显示：优化后模型能更好地模拟人体膳食摄入BPA后血浆中非结合型BPA的浓度变化趋势。模型预测结果与实测值相近，优于既往研究结果，拟合效果良好。通过更新模型结构、优化模型参数和评价模型预测能力与可靠性等，拟建立一个汉族成年人(&gt;18岁)经口摄入BPA的PBTK模型，实现膳食摄入场景下定量预测血液中BPA主要存在形式(未结合态BPA、BPAG和BPAS)的浓度–时间曲线，以及尿液中总BPA的浓度–时间曲线。该模型可为BPA暴露的健康风险评估提供技术支撑。</p></sec><sec id="s2"><title>关键词</title><p>双酚A，生理毒代动力学模型，健康风险评估，人群</p></sec><sec id="s3"><title>Construction of the Physiological Toxicokinetic Model of Bisphenol A<sup> </sup></title><p>Yining Zhang, Man Hu, Ying Zhou<sup>*</sup></p><p>School of Public Health, Fudan University, Shanghai</p><p><img src="//html.hanspub.org/file/1-1740457x5_hanspub.png?20210913095034682" /></p><p>Received: May 22<sup>nd</sup>, 2021; accepted: Jun. 22<sup>nd</sup>, 2021; published: Jun. 30<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/1-1740457x6_hanspub.png?20210913095034682" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>As a high yield chemical, bisphenol A (BPA) is used in many consumer products, such as polycarbonate plastics, epoxy resins, and thermal paper. Due to the prevalence of BPA, the potential effects associated with BPA exposure, and the abnormally high levels of BPA in human serum, have been the focus of debate surrounding the safety of BPA. An important factor in better resolving these controversies is to describe the underlying processes of the pharmacokinetic behavior of BPA in humans physiology-based pharmacokinetics (PBPK) models, which integrate physiological and biochemical information into a mechanistic framework, have been widely used in human health risk assessment to quantitatively describe the pharmacokinetics of chemicals and their metabolites in the human body. Based on previous studies and combined with the latest results of toxicological studies, this study optimized the structure of the model, which was mainly reflected in the following aspects: a) replenish the arterial blood supply of small intestine to achieve blood circulation of small intestine; b) supplement of renal compartment; c) the removal of enterohepatic circulation was based on unbound BPA, which had toxic effects, and the results showed that the optimized model could better simulate the trend of plasma unbound BPA concentration after dietary BPA intake. The predicted results of the model are close to the measured values, which is better than the previous research results. The fitting effect is good By updating the model structure, optimizing the model parameters and evaluating the prediction ability and reliability of the model, a Han adult (&gt;18 years old) to quantitatively predict the time-concentration curves of the major forms of BPA (unbound BPA, BPAG and BPAS) in blood and total BPA in urine under dietary intake scenarios. This model can provide technical support for health risk assessment of BPA exposure.</p><p>Keywords:Bisphenol A, Physiologically Based Toxicokinetics, PBTK, Health Risk Assessment, Human</p><disp-formula id="hanspub.43603-formula2"><graphic xlink:href="//html.hanspub.org/file/1-1740457x7_hanspub.png?20210913095034682"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/1-1740457x8_hanspub.png?20210913095034682" /> <img src="//html.hanspub.org/file/1-1740457x9_hanspub.png?20210913095034682" /></p></sec><sec id="s5"><title>1. 引言</title><p>双酚A (BPA)作为一种高产量的工业用化学品，90%用于制造硬塑料–聚碳酸酯及环氧树脂 [<xref ref-type="bibr" rid="hanspub.43603-ref1">1</xref>]。尽管世界上包括中国在内的一些国家已经禁止在生产婴幼儿食品容器如奶瓶中使用BPA，但是聚碳酸酯和环氧树脂在全球仍被允许用于食品接触材料。例如，中国食品接触用材料法规(GB4806.6-2016)批准可用于生产食品接触材料和制品的塑料树脂，其中包括7种聚碳酸酯和双酚A环氧树脂。2019年我国BPA产量和表观消费量分别约为135.5万吨和195万吨，比2018年同比增长11.44%和18.18%。聚碳酸酯塑料用于制造生活消费品如饮水瓶、可循环使用水桶等贮存容器，而环氧树脂则用作金属质的食物容器罐的保护涂层，以及其他产品包括收银机收据使用的热敏纸、再生纸、牙科的密封剂、医疗器材、电子和汽车零件等。越来越多的证据表明BPA具有内分泌干扰作用 [<xref ref-type="bibr" rid="hanspub.43603-ref2">2</xref>]。在不同啮齿类动物的研究中，已经发现在妊娠期低剂量BPA暴露对儿童的生育能力、大脑发育和行为变化有影响，这表明双酚A具有多种毒性效应 [<xref ref-type="bibr" rid="hanspub.43603-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref7">7</xref>]。美国环境保护署(EPA)已宣布BPA为一种内分泌干扰化学物质，具有生殖、发育、全身毒性、致胖和弱雌激素作用 [<xref ref-type="bibr" rid="hanspub.43603-ref8">8</xref>] - [<xref ref-type="bibr" rid="hanspub.43603-ref13">13</xref>]。人群流行病学调查发现在90%尿液中检测出BPA [<xref ref-type="bibr" rid="hanspub.43603-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref15">15</xref>]，这说明人类普遍暴露于BPA。</p><p>目前，全球多个国家和地区制定了BPA的健康指导值(HBGVs)。欧盟食品安全局(EFSA)确定BPA的每日耐受摄入量(TDI)为4 &#181;g/kg bw。美国EPA给出的BPA的参考剂量(RfD)为50 &#181;g/kg bw。上述的HBGVs均是采用传统动物实验获得NOAEL值外推确定的，由于动物实验研究剂量与人群现实暴露水平往往差异较大，且化学物质在实验动物与人体中代谢动力学和毒作用机制(毒效)存在明显差异，因此推导这些HBGVs存在动物外推到人的不确定性。尽管全球生物监测数据显示人群现实暴露水平远低于上述HBGVs，但是越来越多的人群流行病学研究发现人群长期低剂量BPA暴露与某些健康效应存在关联 [<xref ref-type="bibr" rid="hanspub.43603-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref17">17</xref>]。这提示，现有的健康风险评估技术能不能充分保护人群健康有待探讨。</p><p>目前将生理毒代动力学(PBTK)模型应用于环境污染物的健康风险评估正日益受到学术界关注。PBTK模型是根据人体真实的生理解剖学结构，考虑化学毒物的理化特性、生理学参数和生化代谢参数等，采用数学建模的方法，描述化学毒物在血液和全身器官组织的动力学过程，包括吸收、分布、代谢和排泄 [<xref ref-type="bibr" rid="hanspub.43603-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref19">19</xref>]。它可降低风险评估过程中的不确定性，为食品安全评估标准的制定提供依据。模型构建的过程主要包括：1) 根据毒物毒代动力学过程划分机体中组织器官隔室；2) 编写各个隔室相应的微分方程；3) 确定各隔室参数(血流速度、体积、分配系数等)；4) 软件实现模型构建；5) 模型优化与参数调试；6) 模型确定与应用 [<xref ref-type="bibr" rid="hanspub.43603-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref20">20</xref>]。</p><p>已有一些研究报道了人体BPA的PBTK模型，但是其模型预测能力指标未达到世界卫生组织(WHO)要求。模型预测值和生物监测实测数据之间不一致性受多种因素影响，比如生理生化过程、遗传多态性、暴露水平和暴露途径等 [<xref ref-type="bibr" rid="hanspub.43603-ref21">21</xref>]。所以构建合理的模型结构以及优化模型参数，对于模型预测更为准确显得尤为重要。鉴于此本研究旨在既往研究基础上结合最新的毒理学研究结果 [<xref ref-type="bibr" rid="hanspub.43603-ref22">22</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref24">24</xref>]，通过更新模型结构、优化模型参数和评价模型预测能力与可靠性等，拟建立一个汉族成年人(&gt;18岁)经口摄入BPA的PBTK模型，实现膳食摄入场景下定量预测血液中BPA主要存在形式(未结合态BPA、BPAG和BPAS)的时间–浓度曲线，以及尿液中总BPA的时间–浓度曲线。该模型可为BPA暴露的健康风险评估提供技术支撑。</p></sec><sec id="s6"><title>2. 方法</title><sec id="s6_1"><title>2.1. BPA的PBTK模型构建</title><p>膳食摄入是成年人BPA暴露的主要途径 [<xref ref-type="bibr" rid="hanspub.43603-ref1">1</xref>]。BPA经口摄入后经胃吸收进入小肠，后经门静脉入肝，在肝脏的葡萄糖醛酸化和硫酸化过程代谢之后，经下腔静脉进入血液循环系统，分布于全身多个器官组织。BPA在进入血液循环系统前存在明显的首过消除效应，在经过胃肠道时可被肠道粘膜细胞上的尿苷二磷酸葡萄糖醛酸转移酶(UDP-glucuronosyltransferase, UGT)作用下，代谢为BPA葡糖醛酸苷结合物(BPAG)，经过肠系膜静脉进入肝脏；在肝脏中，大部分BPA在UGTs催化作用下形成BPAG，少量BPA在肝细胞硫酸化代谢酶作用下代谢生成BPA硫酸盐共轭物(BPAS)，如图1所示 [<xref ref-type="bibr" rid="hanspub.43603-ref25">25</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref26">26</xref>]。由于在人体内，非结合型BPA具有生物活性，在小肠、肝脏代谢生成的产物BPAG、BPAS无明显生物活性，所以我们将其设置为单独的两个腔室。</p><p>研究表明BPA在成年人体内的半衰期很短，大约6 h，主要以BPAG和BPAS形式通过肾脏随尿液排出体外 [<xref ref-type="bibr" rid="hanspub.43603-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref24">24</xref>]。故模型中将胃、小肠、肝脏、肾和血液循环系统列为单独腔室。大量研究报道显示BPA具有生殖毒性 [<xref ref-type="bibr" rid="hanspub.43603-ref27">27</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref28">28</xref>]。同时，已有研究报道孕期暴露于低浓度BPA可能对儿童神经和行为发育产生影响 [<xref ref-type="bibr" rid="hanspub.43603-ref29">29</xref>]。故生殖腺和脑作为独立腔室被纳入到模型中。由表1所示，BPA的辛醇–水分配系数对数(LogK<sub>ow</sub>)为3.32 [<xref ref-type="bibr" rid="hanspub.43603-ref30">30</xref>]，对于亲脂性(LogK<sub>ow</sub> &gt; 3)的化学物，需要将脂肪作为独立腔室 [<xref ref-type="bibr" rid="hanspub.43603-ref31">31</xref>]。而对于未单独列为腔室的组织或器官，视为“其它组织器官”作为一个整体腔室考虑。图2为BPA的PBTK模型结构图。所有模型模拟均使用R语言(3.6.3版本)进行，PBTK模型在R包“desolve”中求解。</p><p>图1. 肝脏中BPA的葡萄糖醛酸化及清除途径示意图</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Physical and chemical properties of BP</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >目标物</th><th align="center" valign="middle" >参数 [<xref ref-type="bibr" rid="hanspub.43603-ref30">30</xref>]</th><th align="center" valign="middle" >数值</th></tr></thead><tr><td align="center" valign="middle"  rowspan="8"  >BPA</td><td align="center" valign="middle" >CAS号</td><td align="center" valign="middle" >80-05-7</td></tr><tr><td align="center" valign="middle" >相对分子质量</td><td align="center" valign="middle" >228.29 g/mol</td></tr><tr><td align="center" valign="middle" >分子式</td><td align="center" valign="middle" >C<sub>15</sub>H<sub>16</sub>O<sub>2</sub></td></tr><tr><td align="center" valign="middle" >化学结构式</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="//html.hanspub.org/file/1-1740457x11_hanspub.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >密度</td><td align="center" valign="middle" >1.195~1.2 g/cm<sup>3</sup> (at 25℃)</td></tr><tr><td align="center" valign="middle" >pK<sub>a</sub></td><td align="center" valign="middle" >10.1</td></tr><tr><td align="center" valign="middle" >LogK<sub>ow</sub></td><td align="center" valign="middle" >3.32</td></tr><tr><td align="center" valign="middle" >半衰期</td><td align="center" valign="middle" >6 h</td></tr></tbody></table></table-wrap><p>表1. BPA的理化性质</p></sec><sec id="s6_2"><title>2.2. 模型参数估计</title><p>人体PBTK模型需要的参数包括人体生理学参数、代谢动力学参数和腔室分配系数。PBTK模型参数估计的一个重要原则是符合特定人群的生物学基础。具体到本研究而言，考虑到白种人、黑人与中国黄种人在生理学参数，如体重、体脂等存在明显差异，我们在生理参数的设置上，区分了中国人群与外国人群。其中，外国人群的生理学参数引用Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 设置的参数值，而中国人群的生理学参数参照GBZT 200.3-2014、GBZT 200.2-2007推荐值 [<xref ref-type="bibr" rid="hanspub.43603-ref33">33</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref34">34</xref>]，详见表2。</p><p>图2. BPA的PBTK模型结构图</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Physiological parameters of PBTK model for BP</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >参数</th><th align="center" valign="middle" >符号</th><th align="center" valign="middle" >中国人群</th></tr></thead><tr><td align="center" valign="middle" >心输出量(L/min) (Cardiac Output)</td><td align="center" valign="middle" >QC</td><td align="center" valign="middle" >5.6/5.3*</td></tr><tr><td align="center" valign="middle"  colspan="3"  >血液流速(占心输出量比例) (Velocity of Blood Flow)</td></tr><tr><td align="center" valign="middle" >肝脏(Liver)</td><td align="center" valign="middle" >QLC</td><td align="center" valign="middle" >0.225/0.27*</td></tr><tr><td align="center" valign="middle" >肾脏(Kidney)</td><td align="center" valign="middle" >QKC</td><td align="center" valign="middle" >0.19/0.17*</td></tr><tr><td align="center" valign="middle" >小肠(Small intestine)</td><td align="center" valign="middle" >QlgC</td><td align="center" valign="middle" >0.1/0.11*</td></tr><tr><td align="center" valign="middle" >脂肪(Fat tissue)</td><td align="center" valign="middle" >QFC</td><td align="center" valign="middle" >0.05/0.085*</td></tr><tr><td align="center" valign="middle" >脑(Brain)</td><td align="center" valign="middle" >QBC</td><td align="center" valign="middle" >0.12</td></tr><tr><td align="center" valign="middle" >皮肤(Skin)</td><td align="center" valign="middle" >QSC</td><td align="center" valign="middle" >0.05</td></tr><tr><td align="center" valign="middle" >生殖腺(Gonad)</td><td align="center" valign="middle" >QGC</td><td align="center" valign="middle" >0.0005/0.0002*</td></tr><tr><td align="center" valign="middle"  colspan="3"  >组织器官体积(占人体总量比例) (Tissue Volume)</td></tr><tr><td align="center" valign="middle" >肝脏(Liver)</td><td align="center" valign="middle" >VLC</td><td align="center" valign="middle" >0.022/0.024*</td></tr><tr><td align="center" valign="middle" >肾脏(Kidney)</td><td align="center" valign="middle" >VKC</td><td align="center" valign="middle" >0.0046/0.0048*</td></tr><tr><td align="center" valign="middle" >脂肪(Fat tissue)</td><td align="center" valign="middle" >VFC</td><td align="center" valign="middle" >0.14/0.23*</td></tr><tr><td align="center" valign="middle" >脑(Brain)</td><td align="center" valign="middle" >VBC</td><td align="center" valign="middle" >0.023/0.025*</td></tr><tr><td align="center" valign="middle" >皮肤(Skin)</td><td align="center" valign="middle" >VSC</td><td align="center" valign="middle" >0.038/0.033*</td></tr><tr><td align="center" valign="middle" >血浆(Plasma)</td><td align="center" valign="middle" >VplasmaC</td><td align="center" valign="middle" >0.0411/0.04*</td></tr><tr><td align="center" valign="middle" >生殖腺(Gonad)</td><td align="center" valign="middle" >VGC</td><td align="center" valign="middle" >0.0006/0.0002*</td></tr></tbody></table></table-wrap><p>表2. BPA的PBTK模型生理学参数</p><p>注释：*男性/女性(male/female)。</p><p>BPA的分配系数(Partition Coefficients, Pts)与Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 和Yang [<xref ref-type="bibr" rid="hanspub.43603-ref24">24</xref>] 的研究一致，取值根据Doerge的动物实验数据，其中肾脏的Pts (P<sub>kidney</sub><sub>/serum</sub>)无实验数据，因肾脏为快灌注器官(血流灌注大于0.1 mL/min/g组织) [<xref ref-type="bibr" rid="hanspub.43603-ref35">35</xref>]，其P<sub>kidney</sub><sub>/serum</sub>引用Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 研究中P<sub>rich</sub>参数值，而其他器官组织(主要为肌肉、骨骼等)的Pts值引用Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 研究中P<sub>slow</sub>参数值，见表3。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Partition coefficients of PBTK model for BP</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >脏器</th><th align="center" valign="middle" >符号</th><th align="center" valign="middle" >分配系数</th></tr></thead><tr><td align="center" valign="middle" >肝脏(Liver)</td><td align="center" valign="middle" >PL</td><td align="center" valign="middle" >0.73</td></tr><tr><td align="center" valign="middle" >脂肪(Fat tissue)</td><td align="center" valign="middle" >PF</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >脑(Brain)</td><td align="center" valign="middle" >PB</td><td align="center" valign="middle" >2.8</td></tr><tr><td align="center" valign="middle" >肾(Kidney)</td><td align="center" valign="middle" >PK</td><td align="center" valign="middle" >1.5*</td></tr><tr><td align="center" valign="middle" >皮肤(Skin)</td><td align="center" valign="middle" >PS</td><td align="center" valign="middle" >2.15*</td></tr><tr><td align="center" valign="middle" >生殖腺(Gonad)</td><td align="center" valign="middle" >PGO</td><td align="center" valign="middle" >5.26</td></tr><tr><td align="center" valign="middle" >其他组织(Other tissue)</td><td align="center" valign="middle" >Prest</td><td align="center" valign="middle" >2.7</td></tr></tbody></table></table-wrap><p>表3. BPA的PBTK模型的分配系数</p><p>注释：*QSAR计算获得。</p><p>体外试验发现BPA在肝脏微粒体酶催化下发生葡萄糖醛酸化过程在成年人群男性、女性中未发现显著差异，因此在设置代谢动力学参数时，不区分性别、人种，参考Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 研究中基本模型的参数设置。BPA代谢动力学参数见表4。BPA经膳食摄入后，经小肠上皮细胞吸收进入门静脉，进而进入肝脏的过程采用一阶过程进行描述(K<sub>oral</sub>C, L/h/kg<sup>−0.25</sup>)，BPA在小肠上皮细胞、肝细胞内代谢过程采用米氏方程进行模拟，该参数值同样参考Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>]。</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Metabolic kinetic parameters of PBTK model for BP</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >代谢动力学参数</th><th align="center" valign="middle" >符号</th><th align="center" valign="middle" >原始参数值</th></tr></thead><tr><td align="center" valign="middle" >胃排空速率(Gastric emptying rate)</td><td align="center" valign="middle" >GEC</td><td align="center" valign="middle" >3.5 (L/h/kg<sup>−</sup><sup>0.25</sup>)</td></tr><tr><td align="center" valign="middle" >小肠吸收率(Intestinal absorptivity)</td><td align="center" valign="middle" >K<sub>oral</sub>C</td><td align="center" valign="middle" >2.1 (L/h/kg<sup>−0.25</sup>)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >肝脏葡萄糖醛酸化(Glu in liver)</td><td align="center" valign="middle" >V<sub>max</sub>L_gluC</td><td align="center" valign="middle" >9043 nmol/min/mg of protein</td></tr><tr><td align="center" valign="middle" >K<sub>m</sub>L_glu</td><td align="center" valign="middle" >45,800 nmol</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >小肠葡萄糖醛酸化(Glu in gut)</td><td align="center" valign="middle" >V<sub>max</sub>G_gluC</td><td align="center" valign="middle" >361 nmol/min/mg of protein</td></tr><tr><td align="center" valign="middle" >K<sub>m</sub>G_glu</td><td align="center" valign="middle" >58,400 nmol</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >肝脏硫酸化(Sul in liver)</td><td align="center" valign="middle" >V<sub>max</sub>L_sulC</td><td align="center" valign="middle" >149 nmol/h/g liver</td></tr><tr><td align="center" valign="middle" >K<sub>m</sub>L_sul</td><td align="center" valign="middle" >10,100 nmol</td></tr><tr><td align="center" valign="middle" >小肠上皮细胞体积(Enterocytes volume)</td><td align="center" valign="middle" >enterocytes</td><td align="center" valign="middle" >0.122 (L)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >尿液排泄率(Urine excretion rate)</td></tr><tr><td align="center" valign="middle" >BPA</td><td align="center" valign="middle" >KurineC</td><td align="center" valign="middle" >0.06 (1/h/kg bw <sup>0.75</sup>)</td></tr><tr><td align="center" valign="middle" >BPAG</td><td align="center" valign="middle" >KurinebpagC</td><td align="center" valign="middle" >0.35 (1/h/kg bw <sup>0.75</sup>)</td></tr><tr><td align="center" valign="middle" >BPAS</td><td align="center" valign="middle" >KurinebpasC</td><td align="center" valign="middle" >0.03 (1/h/kg bw <sup>0.75</sup>)</td></tr></tbody></table></table-wrap><p>表4. BPA的PBTK模型代谢动力学参数</p></sec><sec id="s6_3"><title>2.3. 模型校准</title><p>本研究参数校准只针对模型的代谢动力学参数进行校准。常用的方法是利用现有人群研究试验数据与模型预测值进行比对，通过调整代谢动力学参数，优化模型预测性能，最终确定合适的模型代谢动力学参数。本研究利用Thayer [<xref ref-type="bibr" rid="hanspub.43603-ref36">36</xref>] 等人进行的人体口服试验。该试验研究共纳入了14名试验对象，空腹后于早晨通过饼干摄入100 μg/kg bw BPA-D<sub>6</sub>，并在接下来的72小时内，间隔不同时间采集血液、尿液样本，检测样本中非结合型BPA、BPAG、BPAS等含量水平。其中三名研究对象(1男2女)初次试验三天的尿累积总BPA排泄量较低(不到摄入剂量的55%)。因此，排除三名受试对象的数据，最终纳入11人数据进行模型校准。BPA在人体内产生不良健康效应取决于非结合型BPA在血浆中、靶器官中含量水平，因此我们重点关注人膳食摄入BPA后血清中非结合型BPA、BPAG、BPAS含量的时间变化趋势和C<sub>max</sub>值和T<sub>max</sub>值，调整模型代谢动力学参数值，使模型拟合结果尽可能符合试验数据。</p></sec><sec id="s6_4"><title>2.4. 模型评价</title><p>PBTK模型评价指的是评估模型可信度的过程。它包含评估模型的预测能力和可靠性。</p><sec id="s6_4_1"><title>2.4.1. 预测能力</title><p>模型有预测能力指的是模型模拟准确地反映了实际情况。评估化合物PBTK模型预测能力的方法主要分为两种：第一种是对浓度–时间变化趋势进行验证，通过PBTK模型预测的某个组织/器官中化学物的浓度随时间变化的曲线，与试验测定的各个时间点化学品的浓度值比较，视觉观察试验数值是否接近曲线，两者变化趋势是否一致。另一种是对平衡浓度的验证，即通过比较组织/器官中化学物质平衡态浓度的预测值与试验数值的回归系数和均方根误差(RMSE)来判断预测能力，回归系数越高或者RMSE值越低说明预测值与实测值之间的偏差越小，提示模型预测能力越强。这主要针对持久性化学污染物的模型预测 [<xref ref-type="bibr" rid="hanspub.43603-ref37">37</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref38">38</xref>]。BPA的半衰期仅数小时，为短寿命有机污染物，故本研究采用第一种方法评价所构建的PBTK模型预测能力。本研究采用Teeguarden等人报道的人体口服试验 [<xref ref-type="bibr" rid="hanspub.43603-ref39">39</xref>]。该试验研究招募了10名健康成年男性，通过番茄汤摄入30 μg/kg bw BPA-D6，并在接下来的24 h内采集血样，检测BPA、BPAG和BPAS等含量水平。另一方面，本研究利用Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 等人报道的人体PBTK模型(视为模型2)，其同样利用Teeguarden等人报道的人体口服试验数据进行了模型评价，通过比较两个模型预测的Cmax、Tmax和AUC与实测值差异，进一步评价模型的预测能力。</p></sec><sec id="s6_4_2"><title>2.4.2. 可靠性</title><p>评价模型的可靠性主要包括敏感性分析(SA)和不确定性分析(UA)。敏感性分析能够确定对测量指标影响最大的参数。以美国FDA推荐的BPA的ADI值(50 μg/kg/day)为口服摄入量，我们设置模型应用于标准参考人(男性成年人，体重为70 kg)，一次经膳食摄入50 μg/kg的BPA情况。敏感性系数(Sensitivity Coefficient)的确定是基于模型预测的血浆浓度，由每个参数的值变化10%引起的血浆浓度变化，使用前向差分法 [<xref ref-type="bibr" rid="hanspub.43603-ref40">40</xref>]。计算公式(1-1)如下：</p><p>Sensitivity   Coefficient = ( ( A − B ) B ) ( ( C − D ) D ) (1-1)</p><p>其中，A为参数改变后得到的血浆浓度水平，B为原始参数值对应的血浆浓度水平，C为原始参数值增加10%后取值，D为原始参数值。根据WHO/IPCS (2010)推荐，敏感性系数绝对值大于或等于0.5，表示参数具有高敏感性；大于或等于0.2并且低于0.5为中敏感性；大于或等于0.1并且低于0.2为低敏感性 [<xref ref-type="bibr" rid="hanspub.43603-ref41">41</xref>]。</p><p>模型不确定性分析目的是定量分析个体差异导致的模型生理学、解剖学及酶促反应动力学等参数变异性对模型预测造成的影响。蒙特卡罗分析是PBTK模型中最常用的概率抽样方法 [<xref ref-type="bibr" rid="hanspub.43603-ref40">40</xref>] [<xref ref-type="bibr" rid="hanspub.43603-ref42">42</xref>]。蒙特卡罗分析的目的是定性和定量描述模型估计中的变异性和不确定性。通过设置生理参数、(物理化学)分配系数或代谢参数等的分布，进行随机抽样模拟，就可以测量不确定性，从理论上考虑这些参数变化从何种程度上影响模型输出结果。同样在上述应用于标准参考人的情况下，我们参照了Karrer等人 [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 不确定性分析中参数的概率分布设置，进行蒙特卡罗随机抽样100,000次。并且根据文献中不确定度计算方法，计算得到输出值分布的P5、P95百分位数 [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>]。不确定度定义为第95百分位(P95)与剂量量度的P5之比，不确定度系数计算公式为：</p><p>不 确 定 度 系 数 = P 95 P 5 (1-2)</p><p>不确定度分析结果在同一数量级内，则认为可接受 [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>]。</p></sec></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 模型结构与参数校准</title><p>从图3可见，在模型未纳入肠肝循环过程，并且增补了小肠血供以及肾脏腔室的情况下，模型能够较好地模拟人经膳食摄入BPA后血清中非结合型BPA的浓度变化趋势。人体实测血清中BPA、BPAG和BPAS的浓度均值与优化后模型预测的中位浓度–时间曲线有较好的吻合。参数优化后模型所预测的血清中BPAG、BPAS和非结合型BPA的C<sub>max</sub>值和T<sub>max</sub>值均落在实测水平的 y &#175; &#177; SD 之内，提示模型结构合理，且模型代谢动力学参数优化恰当。</p><p></p><p>图3. 参数优化后血清非结合型BPA、BPAG和BPAS的浓度–时间曲线</p></sec><sec id="s7_2"><title>3.2. 模型评价</title><sec id="s7_2_1"><title>3.2.1. 预测能力</title><p>表5比较了本研究构建的BPA的PBTK模型预测的血浆非结合型BPA、BPAG、BPAS代谢动力学参数与实际测量水平以及既往文献报道的模型预测结果 [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>]。本研究模型预测结果与实测值相比，预测浓度峰值C<sub>max</sub>均值为实测值均值的1.3~3.1倍，预测AUC均值为实测值均值的0.36~0.96倍，其中非结合型BPA预测AUC均值与实测均值相似。BPAS的预测达峰时间均值与实测均值相近，BPAG和非结合型BPA时间较实测值提前。</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Comparisons of PBTK model for BPA between currently simulated values, actually detected values and previously reported values (Mean, range</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >指标</th><th align="center" valign="middle"  colspan="2"  >非结合型BPA</th><th align="center" valign="middle"  colspan="2"  >BPAG</th><th align="center" valign="middle"  colspan="2"  >BPAS</th></tr></thead><tr><td align="center" valign="middle" >实测值<sup>a</sup></td><td align="center" valign="middle" >预测值</td><td align="center" valign="middle" >实测值<sup>a</sup></td><td align="center" valign="middle" >预测值</td><td align="center" valign="middle" >实测值<sup>a</sup></td><td align="center" valign="middle" >预测值</td></tr><tr><td align="center" valign="middle" >C<sub>max</sub><sub> </sub>(nM)</td><td align="center" valign="middle" >0.43 (0.3,0.7)</td><td align="center" valign="middle" >1.35 (0.93, 1.70)<sup>b</sup></td><td align="center" valign="middle" >286 (173, 386)</td><td align="center" valign="middle" >367.1 (342.7,399.5)</td><td align="center" valign="middle" >18 (10.4, 29.9)</td><td align="center" valign="middle" >29.11 (21.51, 34.92)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1.31 (0.88, 1.66)<sup>c</sup></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >610 (580, 648)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >22.9 (16.6, 27.9)</td></tr><tr><td align="center" valign="middle" >T<sub>max</sub><sub> </sub>(h)</td><td align="center" valign="middle" >1.6 (0.5,2.2)</td><td align="center" valign="middle" >0.75 (0.64, 0.83)</td><td align="center" valign="middle" >1.2 (0.8, 2.2)</td><td align="center" valign="middle" >0.76 (0.74, 0.78)</td><td align="center" valign="middle" >2.2 (1.2, 5.2)</td><td align="center" valign="middle" >2.16 (2.16, 2.18)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.72 (0.67, 0.77)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.937 (0.933, 0.967)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2.03 (2.00, 2.03)</td></tr><tr><td align="center" valign="middle" >AUC (nM*h per day)</td><td align="center" valign="middle" >2.5 (1.4,5.7)</td><td align="center" valign="middle" >2.39 (1.57, 3.08)</td><td align="center" valign="middle" >680 (570.8, 1210)</td><td align="center" valign="middle" >519.0 (488.8, 561.2)</td><td align="center" valign="middle" >131 (54.9, 298)</td><td align="center" valign="middle" >47.25 (35.49, 56.01)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >4.15 (2.91, 5.15)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1111 (1050, 1210)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >179 (117, 179)</td></tr></tbody></table></table-wrap><p>表5. BPA的PBTK模型模拟值与实测值、既往模型模拟值比较(均值、范围)</p><p>注释：<sup>a</sup>Teeguarden et al. (2015) [<xref ref-type="bibr" rid="hanspub.43603-ref39">39</xref>]；<sup>b</sup>本研究；<sup>c</sup>Cecile Karrer et al. (2018) [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>]。</p></sec><sec id="s7_2_2"><title>3.2.2. 可靠性</title><p>敏感性分析结果如表6所示，BPA的代谢动力学参数，尤其是在肝脏和小肠中葡萄糖醛酸化过程的代谢参数具有高灵敏度，此外肝脏体积参数、BPA的肝脏分配系数以及小肠吸收率、小肠上皮细胞体积参数也具有高灵敏度。胃排空系数具有低灵敏度，其余参数认为其对PBTK模型输出血清非结合型BPA的AUC值无明显影响。</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Sensitivity analysis (AUC of serum unconjugated BPA was output value</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >参数</th></tr></thead><tr><td align="center" valign="middle" >低灵敏度</td><td align="center" valign="middle" >GEC；</td></tr><tr><td align="center" valign="middle" >高灵敏度</td><td align="center" valign="middle" >V<sub>max</sub>L_gluC；K<sub>m</sub>L_glu；V<sub>max</sub>G_gluC；K<sub>m</sub>G_glu；K<sub>oral</sub>C；PL；VLC；enterocytes</td></tr></tbody></table></table-wrap><p>表6. 敏感性分析(血清非结合型BPA的AUC为输出值)</p><p>我们进行了100,000次蒙特卡罗随机抽样，不确定性分析结果如表7所示，模拟AUC值的P95/P5约为10，在一个数量级内，可接受。</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Uncertainty analysis result</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >P5</th><th align="center" valign="middle" >P25</th><th align="center" valign="middle" >P50</th><th align="center" valign="middle" >P75</th><th align="center" valign="middle" >P95</th></tr></thead><tr><td align="center" valign="middle" >AUC (Nm*h per day)</td><td align="center" valign="middle" >3.07</td><td align="center" valign="middle" >6.32</td><td align="center" valign="middle" >10.26</td><td align="center" valign="middle" >16.36</td><td align="center" valign="middle" >31.48</td></tr></tbody></table></table-wrap><p>表7. 不确定性分析结果</p></sec><sec id="s7_2_3"><title>3.2.3. 模型应用</title><p>考虑到人通过饮食摄入长期暴露于BPA，我们通过在12 h内模拟一日三餐的饮食，模拟口腔暴露于BPA。模拟过程一直持续到尿液中总BPA的峰值浓度(Cmax)达到稳定状态。成年人接触BPA的情景通常被视为长期膳食接触，假设成人只食用被BPA污染的食物，每天三餐间隔6小时，模型将运行到10天达到Cmax稳态，如图4。</p><p>图4. 尿液总BPA浓度–时间曲线</p><p>假设成年人(70 kg)终身日摄入BPA量为4 μg/kg bw/day，即EFSA推荐的临时可耐受摄入量(TDI)，输入本研究所构建的PBTK模型估算尿液总BPA浓度为180.6 ng/mL。表8汇总了各国成年人尿液总BPA检出浓度，可见人群实际尿液中BPA浓度(GM, 0.59~3.65 ng/mL)远低于本研究基于PBTK模型推算出的尿液浓度，说明人群实际暴露量低于EFSA推荐的参考限值，健康风险低。</p><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Summary of total urine BPA concentrations detected in adults from different countries (ng/mL</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >国家</th><th align="center" valign="middle" >样本采集时间(年)</th><th align="center" valign="middle" >样本量</th><th align="center" valign="middle" >尿液中总BPA浓度(GM)</th><th align="center" valign="middle" >参考文献</th></tr></thead><tr><td align="center" valign="middle"  rowspan="6"  >美国</td><td align="center" valign="middle" >2003~2004</td><td align="center" valign="middle" >1488</td><td align="center" valign="middle" >2.14</td><td align="center" valign="middle"  rowspan="6"  >[<xref ref-type="bibr" rid="hanspub.43603-ref43">43</xref>]</td></tr><tr><td align="center" valign="middle" >2005~2006</td><td align="center" valign="middle" >1490</td><td align="center" valign="middle" >1.75</td></tr><tr><td align="center" valign="middle" >2007~2008</td><td align="center" valign="middle" >1814</td><td align="center" valign="middle" >1.99</td></tr><tr><td align="center" valign="middle" >2009~2010</td><td align="center" valign="middle" >1914</td><td align="center" valign="middle" >1.79</td></tr><tr><td align="center" valign="middle" >2011~2012</td><td align="center" valign="middle" >1705</td><td align="center" valign="middle" >1.48</td></tr><tr><td align="center" valign="middle" >2013~2014</td><td align="center" valign="middle" >1815</td><td align="center" valign="middle" >1.26</td></tr><tr><td align="center" valign="middle" >中国南京</td><td align="center" valign="middle" >2005~2010</td><td align="center" valign="middle" >325</td><td align="center" valign="middle" >0.59</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.43603-ref44">44</xref>]</td></tr><tr><td align="center" valign="middle" >中国上海</td><td align="center" valign="middle" >2008~2009</td><td align="center" valign="middle" >3423</td><td align="center" valign="middle" >0.81*</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.43603-ref45">45</xref>]</td></tr><tr><td align="center" valign="middle" >德国</td><td align="center" valign="middle" >2005~2008</td><td align="center" valign="middle" >408</td><td align="center" valign="middle" >1.2*</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.43603-ref46">46</xref>]</td></tr><tr><td align="center" valign="middle" >意大利</td><td align="center" valign="middle" >2008~2009</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >3.65</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.43603-ref47">47</xref>]</td></tr><tr><td align="center" valign="middle" >法国</td><td align="center" valign="middle" >2013~2014</td><td align="center" valign="middle" >195</td><td align="center" valign="middle" >3.52</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.43603-ref48">48</xref>]</td></tr><tr><td align="center" valign="middle" >加拿大</td><td align="center" valign="middle" >2012~2013</td><td align="center" valign="middle" >1040</td><td align="center" valign="middle" >1.10</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.43603-ref49">49</xref>]</td></tr></tbody></table></table-wrap><p>表8. 各国成年人尿液总BPA检出浓度汇总(ng/mL)</p><p>注释：*中位值(Median)，GM：几何均值。</p></sec></sec></sec><sec id="s8"><title>4. 讨论</title><p>PBTK模型的构建除了要满足准确描述化学物在生物体内ADME过程的基本要素外，还需要考虑化合物的理化性质(如亲脂性)、人体暴露途径、模型腔室、靶器官和质量守恒等 [<xref ref-type="bibr" rid="hanspub.43603-ref50">50</xref>]。模型腔室的选择需要根据BPA在人体内的代谢动力学和模型在内部剂量度量估计方面的潜在用途(如大脑和生殖腺) [<xref ref-type="bibr" rid="hanspub.43603-ref51">51</xref>]。以Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 和Yang [<xref ref-type="bibr" rid="hanspub.43603-ref24">24</xref>] 构建的模型结构为参照，根据BPA在人体内的毒代动力学过程，以及最新的毒理学研究结果，建立了我国成年人BPA的PBTK模型。模型结构如图2所示，包括9个房室：胃、小肠、肝脏、肾、脑、脂肪、生殖腺、集总隔室以及血液循环。同Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 和Yang [<xref ref-type="bibr" rid="hanspub.43603-ref24">24</xref>] 报道的BPA的PBPK模型结构相比较，本研究所建立的模型的改良主要体现为：1) 补充小肠的动脉血供、实现小肠的血液循环：BPAG是BPA的主要代谢产物，在其代谢解毒过程发挥着重要作用。小肠上皮细胞是BPA代谢的重要部位，经口摄入的非结合型BPA在小肠上皮细胞内发生二相代谢(葡萄糖醛酸化)，此外，血液循环系统中部分非结合型BPA也经小肠上皮细胞代谢，此部分代谢在既往模型中被忽略，本研究中进行了补充；2) 既往动物实验研究发现BPA具有一定的肾脏毒性 [<xref ref-type="bibr" rid="hanspub.43603-ref52">52</xref>]，EFSA制定BPA的TDI水平其相应的不良健康效应为啮齿类动物经BPA暴露后肾脏增重；并且人体排泄BPA的主要途径为尿液排泄，因此补充肾脏隔室；3) 既往研究认为BPA在啮齿类动物中存在肠肝循环过程，而在灵长类动物中无该过程 [<xref ref-type="bibr" rid="hanspub.43603-ref24">24</xref>]；人体口服实验得出BPA在人体中半衰期不超过6 h，半衰期时间较短 [<xref ref-type="bibr" rid="hanspub.43603-ref36">36</xref>]，同样提示人体内无肠肝循环过程，因此，新模型不设置肠肝循环过程。</p><p>在模型结构和参数优化后，将模型预测值与人体口服试验实测值以及既往模型预测值进行比对，发现本研究模型预测结果与实测值相比，预测浓度峰值C<sub>max</sub>均值为实测值均值的1.3~3.1倍，预测AUC均值为实测值均值的0.36~0.96倍，落在或者接近WHO提出的2倍以内的要求，说明模型预测能力良好。且比Karrer [<xref ref-type="bibr" rid="hanspub.43603-ref32">32</xref>] 报道的BPA的PBPK模型预测值更接近实测值，拟合效果良好。</p><p>本研究也存在不足：1) 模型仅考虑了BPA经膳食摄入的暴露途径，未纳入皮肤摄入途径；2) 只针对模型代谢动力学参数做了优化，模型预测的可信度需要进一步改善。</p></sec><sec id="s9"><title>5. 结论</title><p>本研究在既往BPA的PBTK模型基础上，参考新的毒理学研究结果，建立了适合我国成年人的BPA的BPTK模型，通过模型参数的优化，实现了对人体内BPA及其代谢产物BPAG和BPAS含量水平的准确预测，为开展BPA的健康风险评估提供了技术支撑。</p></sec><sec id="s10"><title>基金项目</title><p>国家973重点研发计划项目“基于生理毒代动力学模型(PBTK模型)的环境污染物内外暴露关联机制研究”资助，项目编号：2017YFC1600500。</p></sec><sec id="s11"><title>文章引用</title><p>张益宁,胡 曼,周 颖. 双酚A的生理毒代动力学(PBTK)模型构建研究 Construction of the Physiological Toxicokinetic Model of Bisphenol A[J]. 食品与营养科学, 2021, 10(03): 175-189. https://doi.org/10.12677/HJFNS.2021.103021</p></sec><sec id="s12"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.43603-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Vandenberg, L.N., Hauser, R., Marcus, M., et al. (2007) Human Exposure to Bisphenol A (BPA). Reproductive Toxi-cology, 24, 139-177. &lt;br&gt;https://doi.org/10.1016/j.reprotox.2007.07.010</mixed-citation></ref><ref id="hanspub.43603-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Rubin, B.S. (2011) Bisphenol A: An En-docrine Disruptor with Widespread Exposure and Multiple Effects. Journal of Steroid Biochemistry &amp; Molecular Biology, 127, 27-34. &lt;br&gt;https://doi.org/10.1016/j.jsbmb.2011.05.002</mixed-citation></ref><ref id="hanspub.43603-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Palanza, P.L., Howdeshell, K.L., Parmigiani, S., et al. (2002) Exposure to a Low Dose of Bisphenol A during Fetal Life or in Adulthood Alters Maternal Behavior in Mice. Environmental Health Perspectives, 110, 415-422.  
&lt;br&gt;https://doi.org/10.1016/j.jsbmb.2011.05.002</mixed-citation></ref><ref id="hanspub.43603-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Cabaton, N.J., Canlet, C., Wadia, P.R., et al. (2013) Effects of Low Doses of Bisphenol A on the Metabolome of Perinatally Exposed CD-1 Mice. Environmental Health Perspectives, 121, 586-593. &lt;br&gt;https://doi.org/10.1289/ehp.1205588</mixed-citation></ref><ref id="hanspub.43603-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Snijder, C.A., Heederik, D., Pierik, H., et al. (2013) Fetal Growth and Prenatal Exposure to Bisphenol A: The Generation R Study. Environmental Health Perspectives, 121, 393-398. &lt;br&gt;https://doi.org/10.1289/ehp.1205296</mixed-citation></ref><ref id="hanspub.43603-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Harley, K.G., Gunier, R.B., Kogut, K., Johnson, C., Bradman, A., Calafat, A.M., Eskenazi, B., et al. (2013) Prenatal and Early Childhood Bisphenol A Concentrations and Behavior in School-Aged Children. Environmental Research, 126, 43-50. &lt;br&gt;https://doi.org/10.1016/j.envres.2013.06.004</mixed-citation></ref><ref id="hanspub.43603-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Rubin, B.S. and Soto, A.M. (2009) Bisphenol A: Perinatal Ex-posure and Body Weight. Molecular and Cellular Endocrinology, 304, 55-62. &lt;br&gt;https://doi.org/10.1016/j.mce.2009.02.023</mixed-citation></ref><ref id="hanspub.43603-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kenji, M., Tetsuya, T., Takashi, A., et al. (2002) Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist. Journal of Clinical Endocrinology and Metabolism, 87, 5185-5190. &lt;br&gt;https://doi.org/10.1210/jc.2002-020209</mixed-citation></ref><ref id="hanspub.43603-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Rey, R., Lukas-Croisier, C., et al. (2003) AMH/MIS: What We Know Already about the Gene, the Protein and Its Regulation. Molecular and Cellular Endocrinology, 211, 21-31. &lt;br&gt;https://doi.org/10.1016/j.mce.2003.09.007</mixed-citation></ref><ref id="hanspub.43603-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wei, X., Lee, C., Yeung, W., et al. (2011) Effect of Perinatal and Postnatal Bisphenol A Exposure to the Regulatory Circuits at the Hypothalamus-Pituitary-Gonadal Axis of CD-1 Mice. Reproductive Toxicology (Elmsford, N.Y.), 31, 409-417. &lt;br&gt;https://doi.org/10.1016/j.reprotox.2010.12.002</mixed-citation></ref><ref id="hanspub.43603-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Wang, J., Sun, B., Hou, M., et al. (2013) The Environmental Obesogen Bisphenol A Promotes Adipogenesis by Increasing the Amount of 11β-Hydroxysteroid Dehydrogenase Type 1 in the Adipose Tissue of Children. International Journal of Obesity, 37, 999-1005. &lt;br&gt;https://doi.org/10.1038/ijo.2012.173</mixed-citation></ref><ref id="hanspub.43603-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Vafeladi, M., Roumeliotaki, T., Myridakis, A., et al. (2016) Association of Early Life Exposure to Bisphenol A with Obesity and Cardiometabolic Traits in Childhood. Environmental Research, 146, 379-387.  
&lt;br&gt;https://doi.org/10.1016/j.envres.2016.01.017</mixed-citation></ref><ref id="hanspub.43603-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, R.P., Schuhmacher, M. and Kumar, V. (2017) Review on Crosstalk and Common Mechanisms of Endocrine Disruptors: Scaffolding to Improve PBPK/PD Model of EDC Mixture. Environment International, 99, 1-14.  
&lt;br&gt;https://doi.org/10.1016/j.envint.2016.09.016</mixed-citation></ref><ref id="hanspub.43603-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Calafat, A.M., Ye, X., Wong, L.Y., Reidy, J.A. and Needham, L.L. (2008) Exposure of the U.S. Population to Bisphenol A and 4-Tertiary-Octylphenol: 2003-2004. Environmental Health Perspectives, 116, 39-44.  
&lt;br&gt;https://doi.org/10.1289/ehp.10753</mixed-citation></ref><ref id="hanspub.43603-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Covaci, A., Den Hond, E., Geens, T., Govarts, E., et al. (2015) Urinary BPA Measurements in Children and Mothers from Six European Member States: Overall Results and Determinants of Exposure. Environmental Research, 141, 77-85. &lt;br&gt;https://doi.org/10.1016/j.envres.2014.08.008</mixed-citation></ref><ref id="hanspub.43603-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">李慧艳. 双酚A人群暴露情况和健康风险研究进展[J]. 中国公共卫生, 2018, 34(10): 1442-1445.</mixed-citation></ref><ref id="hanspub.43603-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">高海涛, 李瑞仙, 邸倩南, 等. 我国人群邻苯二甲酸酯类的暴露水平及风险[J]. 癌变•畸变•突变, 2017, 29(6): 471-475.</mixed-citation></ref><ref id="hanspub.43603-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Stadnicka, J., Schirmer, K. and Ashauer, R. (2012) Predicting Concentrations of Organic Chemicals in Fish by Using Toxicokinetic Models. Environmental Science &amp; Technology, 46, 3273-3280. &lt;br&gt;https://doi.org/10.1021/es2043728</mixed-citation></ref><ref id="hanspub.43603-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Khalil, F. and Läer, S. (2011) Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development. Journal of Biomedicine and Biotechnology, 2011, Article ID: 907461. &lt;br&gt;https://doi.org/10.1155/2011/907461</mixed-citation></ref><ref id="hanspub.43603-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">牛志广, 臧雪. 生理药代动力学模型及其在健康风险评价中的应用研究进展[J]. 安全与环境学报, 2015, 15(6): 30-34.</mixed-citation></ref><ref id="hanspub.43603-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, R.P., Schuhmacher, M. and Kumar, V. (2018) The Development of a Pregnancy PBPK Model for Bisphenol A and Its Evaluation with the Available Biomonitoring Data. Science of the Total Environment, 624, 55-68.  
&lt;br&gt;https://doi.org/10.1016/j.scitotenv.2017.12.023</mixed-citation></ref><ref id="hanspub.43603-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Mielke, H. and Gundert-Remy, U. (2009) Bisphenol A Levels in Blood Depend on Age and Exposure. Toxicology Letters, 190, 32-40. &lt;br&gt;https://doi.org/10.1016/j.toxlet.2009.06.861</mixed-citation></ref><ref id="hanspub.43603-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Teeguarden, J.G., Waechter, J.M., Clewell, H.J., et al. (2005) Evaluation of Oral and Intravenous Route Pharmacokinetics, Plasma Protein Binding, and Uterine Tissue Dose Metrics of Bisphenol A: A Physiologically Based Pharmacokinetic Approach. Toxicological Sciences, 85, 823-838. &lt;br&gt;https://doi.org/10.1093/toxsci/kfi135</mixed-citation></ref><ref id="hanspub.43603-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Yang, X., Doerge, D.R., Teeguarden, J.G., et al. (2015) Development of a Physiologically Based Pharmacokinetic Model for Assessment of Human Exposure to Bisphenol A. Toxicology and Applied Pharmacology, 289, 442-456.  
&lt;br&gt;https://doi.org/10.1016/j.taap.2015.10.016</mixed-citation></ref><ref id="hanspub.43603-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Taylor, J.A., Vom Saal, F.S., Welshons, W.V., et al. (2011) Simi-larity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure. Environmental Health Perspectives, 119, 422-430.  
&lt;br&gt;https://doi.org/10.1016/j.taap.2015.10.016</mixed-citation></ref><ref id="hanspub.43603-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Pottenger, L.H., Domoradzki, J.Y., Markham, D.A., et al. (2000) The Relative Bioavailability and Metabolism of Bisphenol A in Rats Is Dependent upon the Route of Administration. Toxicological Sciences: An Official Journal of the Society of Toxicology, 54, 3. &lt;br&gt;https://doi.org/10.1093/toxsci/54.1.3</mixed-citation></ref><ref id="hanspub.43603-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Shi, M.X., et al. (2019) Prenatal Exposure to Bisphenol A Analogues on Female Reproductive Functions in Mice. Toxicological Sciences, 168, 561-571. &lt;br&gt;https://doi.org/10.1093/toxsci/kfz014</mixed-citation></ref><ref id="hanspub.43603-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Delclos, K.B., Camacho, L., Lewis, S.M., et al. (2016) Toxicity Evalua-tion of Bisphenol A Administered by Gavage to Sprague Dawley Rats from Gestation Day 6 through Postnatal Day 90. Toxicological Sciences: An Official Journal of the Society of Toxicology, 153, 212. &lt;br&gt;https://doi.org/10.1093/toxsci/kfw123</mixed-citation></ref><ref id="hanspub.43603-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Dualde, P., Pardo, O., Corpas-Burgos, F., et al. (2019) Biomonitoring of Bisphenols A, F, S in Human Milk and Probabilistic Risk Assessment for Breastfed Infants. Science of the Total En-vironment, 668, 797.  
&lt;br&gt;https://doi.org/10.1016/j.scitotenv.2019.03.024</mixed-citation></ref><ref id="hanspub.43603-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Wu, L.H., Zhang, X.M., Wang, F., et al. (2017) Occurrence of Bisphenol S in the Environment and Implications for Human Exposure: A Short Review. Science of the Total Environ-ment, 615, 87-98.  
&lt;br&gt;https://doi.org/10.1016/j.scitotenv.2017.09.194</mixed-citation></ref><ref id="hanspub.43603-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Chemistry (General). Test No. 315: Bioaccumulation in Sedi-ment-Dwelling Benthic Oligochaetes Oecd Guidelines for the Testing of Chemicals, 2010, Volume 1:1-33(33).</mixed-citation></ref><ref id="hanspub.43603-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Karrer, C., Roiss, T., Goetz, N.V., et al. (2018) Physiologically Based Pharmacokinetic (PBPK) Mod-eling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes. Environmental Health Perspectives, 126, Article ID: 077002.  
&lt;br&gt;https://doi.org/10.1289/EHP2739</mixed-citation></ref><ref id="hanspub.43603-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">中华人民共和国国家卫生和计划生育委员会. GBZ/T 200.3-2014. 辐射防护用参考人, 第3部分: 主要生理学参数[S]. 北京: 中国标准出版社, 2014.</mixed-citation></ref><ref id="hanspub.43603-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">中华人民共和国卫生部. GBZ/T 200.2-2007. 辐射防护用参考人, 第2部分: 主要组织器官质量[S]. 北京: 人民卫生出版社, 2007.</mixed-citation></ref><ref id="hanspub.43603-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Doerge, D.R., Twaddle, N.C., Vanlandingham, M., et al. (2011) Distribution of Bisphenol A into Tissues of Adult, Neonatal, and Fetal Sprague-Dawley Rats. Toxicology and Applied Pharmacology, 255, 261-270.  
&lt;br&gt;https://doi.org/10.1016/j.taap.2011.07.009</mixed-citation></ref><ref id="hanspub.43603-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Thayer, K.A., Doerge, D.R., Hunt, D., et al. (2015) Pharmacoki-netics of Bisphenol A in Humans Following a Single Oral Administration. Environment International, 83, 107-115. &lt;br&gt;https://doi.org/10.1016/j.envint.2015.06.008</mixed-citation></ref><ref id="hanspub.43603-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Pery, A.R.R., Devillers, J., Brochot, C., et al. (2014) A Physio-logically Based Toxicokinetic Model for the Zebra Fish Danio Rerio. Environmental Science &amp; Technology, 48, 781-790. &lt;br&gt;https://doi.org/10.1021/es404301q</mixed-citation></ref><ref id="hanspub.43603-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X. and Wang, W.X. (2015) Physiologically Based Pharmacokinetic Model for Inorganic and Methylmercury in a Marine Fish. Environmental Science &amp; Technology, 49, 10173-10181. &lt;br&gt;https://doi.org/10.1021/acs.est.5b02301</mixed-citation></ref><ref id="hanspub.43603-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Teeguarden, J.G., Twaddle, N.C., et al. (2015) 24-Hour Human Urine and Serum Profiles of Bisphenol A: Evidence against Sublingual Absorption Following Ingestion in Soup. Toxicology and Applied Pharmacology, 288, 131-142.  
&lt;br&gt;https://doi.org/10.1016/j.taap.2015.01.009</mixed-citation></ref><ref id="hanspub.43603-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Andersen, M. (2010) Quantitative Modeling in Toxicology. John Wiley &amp; Sons, Ltd., Hoboken.</mixed-citation></ref><ref id="hanspub.43603-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Meek, M.E., Ba Rton, H.A., Bessems, J.G., et al. (2013) Case Study Illustrating the WHO IPCS Guidance on Characterization and Application of Physiologically Based Pharmacokinetic Models in Risk Assessment. Regulatory Toxicology and Pharmacology, 66, 116-129. &lt;br&gt;https://doi.org/10.1016/j.taap.2015.01.009</mixed-citation></ref><ref id="hanspub.43603-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Bernillon, P. and Bois, F.Y. (2000) Statistical Issues in Toxicoki-netic Modeling: A Bayesian Perspective. Environmental Health Perspectives, 108, 883-893. &lt;br&gt;https://doi.org/10.1289/ehp.00108s5883</mixed-citation></ref><ref id="hanspub.43603-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">CDC. Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables.  
&lt;br&gt;https://www.cdc.gov/exposurereport</mixed-citation></ref><ref id="hanspub.43603-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Chen, M., Zhu, P., Xu, B., et al. (2012) Determination of Nine Envi-ronmental Phenols in Urine by Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Journal of Analytical Toxicology, 36, 608-615.  
&lt;br&gt;https://doi.org/10.1093/jat/bks072</mixed-citation></ref><ref id="hanspub.43603-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Ning, G., Bi, Y., Wang, T., et al. (2011) Relationship of Urinary Bisphenol A Concentration to Risk for Prevalent Type 2 Diabetes in Chinese Adults: A Cross-Sectional Analysis. Annals of Inter-nal Medicine, 155, 368-374.  
&lt;br&gt;https://doi.org/10.7326/0003-4819-155-6-201109200-00005</mixed-citation></ref><ref id="hanspub.43603-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Völkel, W., Kiranoglu, M. and Fromme, H. (2008) Determination of Free and Total Bisphenol A in Human Urine to Assess Daily Uptake as a Basis for a Valid Risk Assessment. Toxicology Letters, 179, 155-162.  
&lt;br&gt;https://doi.org/10.1016/j.toxlet.2008.05.002</mixed-citation></ref><ref id="hanspub.43603-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Melzer, D., Harries, L., Cipelli, R., et al. (2011) Bisphenol A Ex-posure Is Associated with in Vivo Estrogenic Gene Expression in Adults. Environmental Health Perspectives, 119, 1788-1793. &lt;br&gt;https://doi.org/10.1289/ehp.1103809</mixed-citation></ref><ref id="hanspub.43603-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Ndaw, S., Remy, A., Jargot, D., et al. (2016) Occupational Exposure of Cashiers to Bisphenol A via Thermal Paper: Urinary Biomonitoring Study. International Archives of Occu-pational &amp; Environmental Health, 89, 935-946.  
&lt;br&gt;https://doi.org/10.1007/s00420-016-1132-8</mixed-citation></ref><ref id="hanspub.43603-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Bushnik, T., Haines, D., Levallois, P., et al. (2010) Lead and Bi-sphenol A Concentrations in the Canadian Population. Health Reports, 21, 7-18.</mixed-citation></ref><ref id="hanspub.43603-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">张书莹, 王中钰, 陈景文. 生理毒代动力学模型在化学品生态风险评价中的应用[J]. 科学通报, 2017, 62(35): 4139-4150.</mixed-citation></ref><ref id="hanspub.43603-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Fisher, J.W., Twaddle, N.C., Vanlandingham, M., et al. (2011) Pharmacokinetic Modeling: Prediction and Evaluation of Route De-pendent Dosimetry of Bisphenol A in Monkeys with Extrapolation to Humans. Toxicology and Applied Pharmacology, 257, 122-136. &lt;br&gt;https://doi.org/10.1016/j.taap.2011.08.026</mixed-citation></ref><ref id="hanspub.43603-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Tyl, R.W., Myers, C.B., Marr, M.C., et al. (2008) Two-Generation Reproductive Toxicity Study of Dietary Bisphenol A in CD-1 (Swiss) Mice. Toxicological Sciences: An Official Journal of the Society of Toxicology, 104, 362-384.</mixed-citation></ref></ref-list></back></article>